Compare Dharma Polimetal Tbk. (DRMA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dharma Polimetal Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Dharma Polimetal Tbk. trades at Rp985 (market cap 4.64T, 531.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Dharma Polimetal Tbk. is far larger — about 7.3× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 531.1K). Which is the better fit depends on your goals.
| DRMA | LABS | |
|---|---|---|
Market Cap | 4.64T | 635.95B |
Volume | 531.1K | 843K |
Lot | 5.31K | 8.43K |
Turnover | 523.32M | 137.6M |
Average Price | 985.35 | 163.22 |
Value | 523.32M | 137.6M |
Indicative Equilibrium Price | 985 | 165 |
Indicative Equilibrium Volume | 125 | 246 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dharma Polimetal Tbk.
PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.
Read more on DRMA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
